# A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-07-15

Status: ACTIVE_NOT_RECRUITING · Sponsor: Regeneron Pharmaceuticals · Condition: Non-small Cell Lung Cancer

- Company: Regeneron Pharmaceuticals
- Sector: Non-small Cell Lung Cancer
- Primary source: https://clinicaltrials.gov/study/NCT05800015

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.
